Senior Director, New Product Planning – Oncology Lead
Jazz Pharmaceuticals
June 24, 2026
Remote friendly (Palo Alto, CA)
United States
Marketing
Responsibilities:
- Lead commercial due diligence for external assets (pre-clinical through commercial stage), including unmet need, target patient/treater populations, competitive landscape, and market access.
- Build and own long-term revenue forecasts underpinning deal valuation; develop planning/upside/downside scenarios based on clinical outcomes, label claims, payer restrictions, competitive dynamics, and commercialization options.
- Execute/commission/synthesize rapid-turnaround primary and secondary market research (e.g., KOL interviews, payer boards) to validate clinical value propositions during deal sprints.
- Collaborate cross-functionally (e.g., executive leadership, Market Access, Business Units/Commercial, regional stakeholders) to develop and socialize deal assumptions.
- Define the strategic thesis for each transaction (fit within Oncology strategy; synergies and risks).
- Help define therapeutic “areas of interest” for business development and identify market white space.
- Drive next-generation diligence by integrating tech-forward tools and predictive analytics into commercial diligence/valuation.
- Champion continuous learning and adaptability within deal teams.
- Create and deliver investment committee/board presentations; provide objective risk assessments to support “Go/No-Go” decisions.
Qualifications:
- Bachelor’s degree required; MBA or advanced scientific degree (PhD/MD/PharmD) strongly preferred.
- 15+ years in pharma; at least 10 years in corporate development, business development, or strategic consulting.
- Deep oncology and commercial diligence expertise; proven track record leading commercial diligence (M&A or licensing).
- Advanced deal-valuation forecasting; ability to translate complex clinical data into commercial value drivers.
- Experience managing multiple diligence projects under tight timelines.
Skills/Success Metrics:
- High-quality, accurate commercial insights; fast diligence-to-decision.
- Excellent written/oral communication and influencing top-level biotech/pharma leadership.
Travel: 10–20%
- Lead commercial due diligence for external assets (pre-clinical through commercial stage), including unmet need, target patient/treater populations, competitive landscape, and market access.
- Build and own long-term revenue forecasts underpinning deal valuation; develop planning/upside/downside scenarios based on clinical outcomes, label claims, payer restrictions, competitive dynamics, and commercialization options.
- Execute/commission/synthesize rapid-turnaround primary and secondary market research (e.g., KOL interviews, payer boards) to validate clinical value propositions during deal sprints.
- Collaborate cross-functionally (e.g., executive leadership, Market Access, Business Units/Commercial, regional stakeholders) to develop and socialize deal assumptions.
- Define the strategic thesis for each transaction (fit within Oncology strategy; synergies and risks).
- Help define therapeutic “areas of interest” for business development and identify market white space.
- Drive next-generation diligence by integrating tech-forward tools and predictive analytics into commercial diligence/valuation.
- Champion continuous learning and adaptability within deal teams.
- Create and deliver investment committee/board presentations; provide objective risk assessments to support “Go/No-Go” decisions.
Qualifications:
- Bachelor’s degree required; MBA or advanced scientific degree (PhD/MD/PharmD) strongly preferred.
- 15+ years in pharma; at least 10 years in corporate development, business development, or strategic consulting.
- Deep oncology and commercial diligence expertise; proven track record leading commercial diligence (M&A or licensing).
- Advanced deal-valuation forecasting; ability to translate complex clinical data into commercial value drivers.
- Experience managing multiple diligence projects under tight timelines.
Skills/Success Metrics:
- High-quality, accurate commercial insights; fast diligence-to-decision.
- Excellent written/oral communication and influencing top-level biotech/pharma leadership.
Travel: 10–20%